Research - Columbus Memory Center

17 06, 2021

CMC gives the first infusion by a non-university based medical practice
Gallery
CMC gives the first infusion by a non-university based medical practice

Alzheimer's and Dementia, Health and Wellbeing, Research

CMC gives the first infusion by a non-university based medical practice

By Cole Archer|2021-07-23T17:52:58+00:00June 17, 2021|Alzheimer's and Dementia, Health and Wellbeing, Research|Comments Off on CMC gives the first infusion by a non-university based medical practice

"We finally have a drug available for Alzheimer’s disease that modifies and slows the illness" - Dr. Jonathan Liss For Immediate Release, June 17, 2021 Columbus, GA – Columbus Memory Center (CMC) is excited to announce the first infusion of the new Alzheimer’s drug, Aduhelm, by a non-university based medical practice. This milestone also represents the first infusion of this FDA approved therapy for Alzheimer’s disease in the Southeastern United States and only the second patient to be treated in the country. The patient, and his family, wish to [...]

10 06, 2021

A Giant Step Forward in the Fight to Eliminate Alzheimer’s Disease
Gallery
A Giant Step Forward in the Fight to Eliminate Alzheimer’s Disease

Alzheimer's and Dementia, Health and Wellbeing, Research

A Giant Step Forward in the Fight to Eliminate Alzheimer’s Disease

By Cole Archer|2021-07-23T17:57:17+00:00June 10, 2021|Alzheimer's and Dementia, Health and Wellbeing, Research|Comments Off on A Giant Step Forward in the Fight to Eliminate Alzheimer’s Disease

FDA instituted its Accelerated Approval Program for Biogen's Aduhelm (aducanumab) This week, the FDA approved Aduhelm (aducanumab), “the first novel therapy approved for Alzheimer’s disease since 2003.” Columbus Memory Center is proud to have played an important role in aducanumab’s journey to FDA approval and will continue research for this and many other drugs that will aid in our fight to end Alzheimer’s disease. “This is a major moment in medical history. It is a moment I have been working towards for 30 years. [...]

18 03, 2021

A Glowing Review of Dr. Liss and his Colleagues
Gallery
A Glowing Review of Dr. Liss and his Colleagues

Alzheimer's and Dementia, Research

A Glowing Review of Dr. Liss and his Colleagues

By Cole Archer|2021-07-14T20:42:14+00:00March 18, 2021|Alzheimer's and Dementia, Research|Comments Off on A Glowing Review of Dr. Liss and his Colleagues

The Journal of Internal Medicine recently published an editorial, “Alzheimer’s disease in primary care: new tools for improved and simplified diagnostics,” by H. Zetterberg and E. Stomrud, that gives high praise to our own Dr. Liss. Liss and his colleagues participated in the paper “Practical Recommendations for Timely, Accurate Diagnosis of Symptomatic Alzheimer’s Disease (MCI and Dementia) in Primary Care: A Review and Synthesis,” which was published in mid-January in the same journal. Zetterberg and Stomrud call the paper a “must-read for any clinician caring for patients in mid- to [...]

10 03, 2021

Racial disparities in memory related healthcare
Gallery
Racial disparities in memory related healthcare

Alzheimer's and Dementia, Community Outreach, Research

Racial disparities in memory related healthcare

By Cole Archer|2021-07-14T20:42:27+00:00March 10, 2021|Alzheimer's and Dementia, Community Outreach, Research|Comments Off on Racial disparities in memory related healthcare

The Alzheimer’s Association produced a troubling report that outlines racial disparities in memory related health care. As a nation, we must do better to eliminate these differences in care. Columbus Memory Center is blessed to employ a multi-racial staff and takes great pride in treating every family with dignity and respect. While our diverse patient population, and associated kind comments, leads us to believe that we have earned the trust of the entire community, we will continue to work hard in maintaining this excellence. From a research standpoint, it is [...]

12 11, 2019

Biogen’s Reversal Could Change the Course of Alzheimer’s
Gallery
Biogen’s Reversal Could Change the Course of Alzheimer’s

Research

Biogen’s Reversal Could Change the Course of Alzheimer’s

By Jonathan Liss|2022-09-26T19:22:52+00:00November 12, 2019|Research|Comments Off on Biogen’s Reversal Could Change the Course of Alzheimer’s

CMC on the Verge of Alzheimer’s Game-Changer Failed Alzheimer’s study could have led to disease modifying medication Pharmaceutical company, Biogen, recently revealed a plan to resurrect its experimental Alzheimer’s drug, aducanumab, months after the study’s failure and abrupt closure. Biogen began using aducanumab in 2017 to remove sticky proteins in the brain, called beta amyloid, that are linked to Alzheimer’s disease. Aducanumab (BIIB037) is a human monoclonal antibody studied for the treatment of early Alzheimer’s. Columbus Memory Center was one of the first in the world to [...]

10 09, 2019

Dr. Liss Thanks Generation Study Participants

By Jonathan Liss|2022-09-26T19:23:15+00:00September 10, 2019|Research|Comments Off on Dr. Liss Thanks Generation Study Participants

Written By Tyrone McCoyThank you for participating in the Generation research program. We are saddened to share that pharmaceutical companies, Novartis, and Amgen, recently announced their decision to discontinue studies into this potential preventative Alzheimer’s disease therapy. The trial and treatment will no longer be available at Columbus Memory Center.I am certain you are disappointed, as am I. However, a team of independent scientific observers felt that potential harm could come to participants. Therefore, most of the studies have to be stopped. For those of you that received active medication, [...]

8 08, 2019

When Alzheimer’s Gave Lemons, He Made Lemonade
When Alzheimer’s Gave Lemons, He Made Lemonade

Alzheimer's and Dementia, Research

When Alzheimer’s Gave Lemons, He Made Lemonade

By Jonathan Liss|2022-09-26T19:23:48+00:00August 8, 2019|Alzheimer's and Dementia, Research|Comments Off on When Alzheimer’s Gave Lemons, He Made Lemonade

Alabama man turns diagnosis into treasured gifts for children Written By Tyrone McCoy An Alzheimer’s disease diagnosis is often regarded as an end to a person’s life as they know it. However, with a good attitude and fresh perspective, it could serve as a new beginning or even a well-spring for greatness. Such is the case for Mr. Charles Clegg, who received this diagnosis in 2018, and is now bringing smiles to the faces of children worldwide as a direct result. Relying on his Baptist faith to maintain optimism, Mr. [...]